Abstract:Tumors pose a significant threat to human health, and their occurrence and fatality rates are on the rise each year. Accurate tumor diagnosis is crucial in preventing untimely treatment and late-stage metastasis, thereby reducing mortality. To address this, we have developed a novel type of hybrid nanogels called γ-Fe2O3@PNIPAM/PAm/CTS, which contain iron oxide nanoparticles and poly(N-isopropyl acrylamide)/poly(acrylamide)/chitosan. The rational for this study relies on the concept that thermosensitive PNIPAM has the ability to contract when exposed to the elevated temperature conditions found within tumors. This contraction leads to a dense clustering of the high-loading γ-Fe2O3 nanoparticles within the nanogel, thus greatly enhancing the capabilities of MRI imaging. Additionally, the amino groups in chitosan on the particle surface can be converted into ammonium salts under mildly acidic conditions, allowing for an increase in the charge of the nanogel specifically at the slightly acidic tumor site. Consequently, it promotes the phagocytosis of tumor cells and effectively enhances the accumulation and retention of nanogels at the tumor site. The synthesis of the hybrid nanogels involves a surfactant-free emulsion copolymerization process, where vinyl-modified γ-Fe2O3 superparamagnetic nanoparticles are copolymerized with the monomers in the presence of chitosan. We have optimized various reaction parameters to achieve a high loading content of the superparamagnetic nanoparticles, reaching up to 60%. The achieved r2 value of 517.74 mM-1S-1 significantly surpasses that of the clinical imaging contrast agent Resovist (approximately 151 mM-1S-1). To assess the performance of these magnetic nanogels, we conducted experiments using Cal27 oral tumors and 4T1 breast tumors in animal models. The nanogels exhibited temperature- and pH-sensitivity, enabling magnetic targeting and enhancing diagnosis through MRI imaging. The results demonstrated the potential of these hybrid nanogels as contrast agents for magnetic targeting in biomedical applications.

Magnetic microswarm for MRI contrast enhancer

Subwavelength Dielectric Waveguide for Efficient Travelling-Wave Magnetic Resonance Imaging

Magnetically induced magnetosome chain (MAGiC):A biogenic magnetic-particle-imaging tracer with high performance and navigability

Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

Bimagnetic Core/Shell Nanoprobes with Tunable Exchange Coupling for High Resolution and Sensitive Magnetic Particle Imaging

Fe Doped Magnetic Nanodiamonds Made by Ion Implantation as Contrast Agent for MRI

Recent Advances on Stimuli-Responsive Macromolecular Magnetic Resonance Imaging (MRI) Contrast Agents

MRI driven magnetic microswimmers

Weak Ion-Exchange Based Magnetic Swarm for Targeted Drug Delivery and Chemotherapy

Magnetic Field-Optimized Paramagnetic Nanoprobe for T2/T1 Switchable Histopathological-Level MRI

Monte Carlo study of an unconventional superconducting phase in iridium oxide J(eff)=1/2 Mott insulators induced by carrier doping.

Enhancing MRI imaging through high loading of superparamagnetic nanogels with high sensitivity to the tumor environment

MOF-based magnetic microrobot swarms for pH-responsive targeted drug delivery

Microfluidic synthesis of ultra-small magnetic nanohybrids for enhanced magnetic resonance imaging

Time-Dependent T-1-T-2 Switchable Magnetic Resonance Imaging Realized by C(rgdyk) Modified Ultrasmall Fe3O4 Nanoprobes

Ligand‐Mediated Magnetism‐Conversion Nanoprobes for Activatable Ultra‐High Field Magnetic Resonance Imaging

Enhancement of magnetic resonance imaging with metasurfaces

Magnetic-susceptibility-dependent ratiometric probes for enhancing quantitative MRI

Design and Control of the Magnetically Actuated Micro/Nanorobot Swarm toward Biomedical Applications

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Inequalities of Hermite-Hadamard type involving an s-convex function with applications